Ebit (Esaote Group) and DiA Imaging Analysis Expand Ultrasound AI offering on SUITESTENSA Cardiovascular PACS System
Published: October 20, 2021
11th October 2021 – Featured on Cision PR Newswire – GENOA, Italy and BE’ER SHEVA, Israel, Oct. 11, 2021 /PRNewswire/ — Ebit (Esaote Group), a leading Italian healthcare IT company and DiA Imaging Analysis Ltd, the leading provider of AI-powered solutions, today launched the addition of DiA’s LVivo RV for automated assessment of the right ventricle (RV) size and function onto Ebit’s SUITENSENSA Cardiovascular PACS system.
SUITESTENSA is a vendor-neutral comprehensive enterprise platform that allows physicians to archive, manage and share data reports and clinical images produced by any cardiological equipment. LVivo RV will be offered in addition to DiA’s full suite of automated left ventricle (LV) size and function solutions available on SUITESTENSA PACS – LVivo EF, LVivo Strain and LVivo SWM for automated analysis of the left ventricle. LVivo Toolbox as part of SUITESTENSA PACS supports clinicians’ decisions with more objective and fast cardiac indications, helping to improve their workflow. Ebit is offering LVivo Toolbox as an integrated part of its PACS viewer in order to assure the best user experience and efficient workflow for ultrasound users.Share on LinkedIn
Ultrasound AIPublication Date November 2023
This is a proposal for our Market Impact Report on the global opportunity for AI in ultrasound, publication date November 2023.
Find out more